TY - JOUR
T1 - Mitoparan and target-selective chimeric analogues
T2 - Membrane translocation and intracellular redistribution induces mitochondrial apoptosis
AU - Jones, Sarah
AU - Martel, Cecile
AU - Belzacq-Casagrande, Anne Sophie
AU - Brenner, Catherine
AU - Howl, John
N1 - Funding Information:
We are indebted to Keith Holding for his outstanding technical assistance. J. Howl and S. Jones and would also like to thank the Samantha Dickson Brain Tumour Trust for their financial support. C. Brenner is supported by grants funded by Agence Nationale pour la Valorisation de la Recherche (ANVAR), n°A0505001, Association pour la recherche sur le Cancer (ARC) and by the Institut National du Cancer (INCa, n°0610-3D1616-123/PL-2006).
PY - 2008/5/1
Y1 - 2008/5/1
N2 - Mastoparan, and structurally-related amphipathic peptides, may induce cell death by augmentation of necrotic and/or apoptotic pathways. To more precisely delineate cytotoxic mechanisms, we determined that [Lys5,8Aib10]mastoparan (mitoparan) specifically induces apoptosis of U373MG and ECV304 cells, as demonstrated by endonuclease and caspase-3 activation and phosphatidylserine translocation. Live cell imaging confirmed that, following translocation of the plasma membrane, mitoparan specifically co-localizes with mitochondria. Complementary studies indicated that mitoparan induces swelling and permeabilization of isolated mitochondria, through cooperation with a protein of the permeability transition pore complex VDAC, leading to the release of the apoptogenic factor, cytochrome c. N-terminal acylation of mitoparan facilitated the synthesis of chimeric peptides that incorporated target-specific address motifs including an integrin-specific RGD sequence and a Fas ligand mimetic. Significantly, these sychnologically-organised peptides demonstrated further enhanced cytotoxic potencies. We conclude that the cell penetrant, mitochondriotoxic and apoptogenic properties of mitoparan, and its chimeric analogues, offer new insights to the study and therapeutic induction of apoptosis.
AB - Mastoparan, and structurally-related amphipathic peptides, may induce cell death by augmentation of necrotic and/or apoptotic pathways. To more precisely delineate cytotoxic mechanisms, we determined that [Lys5,8Aib10]mastoparan (mitoparan) specifically induces apoptosis of U373MG and ECV304 cells, as demonstrated by endonuclease and caspase-3 activation and phosphatidylserine translocation. Live cell imaging confirmed that, following translocation of the plasma membrane, mitoparan specifically co-localizes with mitochondria. Complementary studies indicated that mitoparan induces swelling and permeabilization of isolated mitochondria, through cooperation with a protein of the permeability transition pore complex VDAC, leading to the release of the apoptogenic factor, cytochrome c. N-terminal acylation of mitoparan facilitated the synthesis of chimeric peptides that incorporated target-specific address motifs including an integrin-specific RGD sequence and a Fas ligand mimetic. Significantly, these sychnologically-organised peptides demonstrated further enhanced cytotoxic potencies. We conclude that the cell penetrant, mitochondriotoxic and apoptogenic properties of mitoparan, and its chimeric analogues, offer new insights to the study and therapeutic induction of apoptosis.
KW - Apoptosis
KW - Cell penetrating peptides
KW - Chimerism
KW - Mastoparan
KW - Mitochondria
UR - http://www.scopus.com/inward/record.url?scp=41949109107&partnerID=8YFLogxK
U2 - 10.1016/j.bbamcr.2008.01.009
DO - 10.1016/j.bbamcr.2008.01.009
M3 - Article
C2 - 18267123
AN - SCOPUS:41949109107
SN - 0167-4889
VL - 1783
SP - 849
EP - 863
JO - Biochimica et Biophysica Acta - Molecular Cell Research
JF - Biochimica et Biophysica Acta - Molecular Cell Research
IS - 5
ER -